To the Editor: I was interested to read the results of Sweidan and colleagues’ study of drug interaction alerts in prescribing and dispensing software.1 I believe their use of the terms “sensitivity” and “specificity” differ from the standard definitions, which are usually:
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Springwood Group General Practice, Brisbane, QLD.
Correspondence: ian.cheong@acm.org
- 1. Sweidan M, Reeve JF, Brien JE, et al. Quality of drug interaction alerts in prescribing and dispensing software. Med J Aust 2009; 190: 251-254. <MJA full text>
- 2. Riegelman RK. Studying a study and testing a test: how to read the medical evidence. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2004: 158.
- 3. Morimoto T, Gandhi TK, Seger AC, et al. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 2004; 13: 306-314.
- 4. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 29-34.
- 5. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 2003; 163: 1409-1416.
- 6. Kuperman GJ, Bobb A, Payne TH, et al. Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 2007; 14: 29-40.
Online responses are no longer available. Please refer to our instructions for authors page for more information.